tiprankstipranks
Bausch Health says Bausch + Lomb sale exploration process ‘ongoing’
The Fly

Bausch Health says Bausch + Lomb sale exploration process ‘ongoing’

Bausch Health Companies (BHC) issued the following statement in response to a request from the Canadian Investment Regulatory Organization: “As previously disclosed, the Company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation (BLCO) makes strategic sense. The Bausch Health Board of Directors authorized management and management of its subsidiary, Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction. While the Company normally would not comment on deal negotiations, CIRO requested confirmation of a potential sale process given stock volatility often associated with market rumors. Bausch Health does not intend to provide additional detail until further disclosure is appropriate or necessary.”

Invest with Confidence:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App